Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates

Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 5.71%. A quarter ago, it was expected that this lifesciences research company would post a loss of $0.32 per share when it actually produced a loss of $0.30, delivering a surprise of 6.25%. Over the last four qua ...